TrialMovement disorders clinical practice2025

Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial.

Angelo Antonini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.